CAJ | 학술논문

目的：探究心肌病合并心功能不全患者采用乙胺碘呋酮的治疗方法和疗效。方法选取2013年3月～2014年7月收治的34例心肌病合并心功能不全患者进行治疗，随机分组，实验组19例患者采用乙胺碘呋酮的治疗，对照组15例患者给予常规干预，对比疗效。结果实验组治疗有效率为94.74%，对照组治疗有效率为80.0%。差异较大，且实验组患者的心功能好于对照组，有统计学意义（P<0.05）。结论心肌病合并心功能不全患者可使身体症状得到改善，安全性高，提高患者的生活质量。
목적：탐구심기병합병심공능불전환자채용을알전부동적치료방법화료효。방법선취2013년3월～2014년7월수치적34례심기병합병심공능불전환자진행치료，수궤분조，실험조19례환자채용을알전부동적치료，대조조15례환자급여상규간예，대비료효。결과실험조치료유효솔위94.74%，대조조치료유효솔위80.0%。차이교대，차실험조환자적심공능호우대조조，유통계학의의（P<0.05）。결론심기병합병심공능불전환자가사신체증상득도개선，안전성고，제고환자적생활질량。
Objective Amiodarone medication treatment approach and its effect to patients of cardiomyopathy complicated with heart failure are to be investigated. Methods Chose 34 patients of cardiomyopathy complicated with heart failure that were treated in hospital from March 2013 to July 2014 and separate them into two groups at random,19 patients in study group were given amiodarone medication treatment,while 15 patients in control group were given conventional intervention treatment,and then compared treatment effects between two groups. Results Treatment efficacy in study group was up to 94.74%,while treatment efficacy in control group was 80.0%; besides,patients’heart function improvements in study group were better than that in control group,there was a treatment differential between two groups,and such a differential had statistic value(P<0.05). Conclusion Amiodarone medication treatment is of efficacy in treatment of patients of cardiomyopathy complicated with heart failure; it is effective to promote patients’clinical symptom with medication safety and improve their quality of life.